Research 2030 Elsevier

For this compilation episode, we’ve delved into our archives to explore how the role of universities in their communities is evolving and the many factors driving that change.

Find our full show notes here.

You will hear clips from the following Research 2030 episodes (listed in order of appearance):
Societal Impact, SDG Research & Universities featuring Professor Aluísio Segurado, Head of Research at the University of São Paulo in BrazilPerspectives on rankings from a young university featuring César Wazen, Director of Scholarships and Partnerships at Qatar UniversityGlobal North-South Collaboration: A perspective from South Africa featuring Dr. Jennifer Thomson, Emeritus Professor in the Department of Molecular and Cell Biology at the University of Cape TownCollaboration between industry and academia featuring GlaxoSmithKline’s Director of Academic Liaison, Malcolm SkingleWhy two heads are better than one - the power of university-industry collaborations featuring Tony Boccanfuso, President and CEO of the University Industry Demonstration Partnership (UIDP)Collaboration and data as drivers of progress featuring Elsevier’s Senior Vice President of Research Networks, Prof. Carlos Henrique de Brito CruzBlending societal impact and research strategy - Two experts explain what needs to change and why featuring Director of AESIS Anika S. Duut van Goor and senior institutional capacity builder Toñi CaroResearch strategy: A conversation with Lesley Thompson & Holly Falk-Krzesinski featuring two of Elsevier’s Senior Vice Presidents whose roles see them work closely with university leadersThe value of creating a healthy research culture featuring neuroscientist, psychiatrist, book author and mindfulness expert, Dr. Judson BrewerBye, bye, blue sky? Part 1: A conversation with Lee Cronin featuring the Regius Professor of Chemistry at University of GlasgowBye, bye, blue sky? Part 2: A conversation with Andrew Hamilton featuring the President of New York University (NYU)

In this episode, Director of AESIS Anika S. Duut van Goor and senior institutional capacity builder Toñi Caro, discuss the nuts and bolts of societal impact. They consider: 
What it will take to build a true societal impact culture  Who can play a key role The importance of patience and perseverance The power of ambassadors of change "[For societal impact] you need the incentives, you need the policies, you need the skills, you need the people who are excited to move forward, you need the infrastructures… it is an all-encompassing way of working."
- Anika S. Duut van Goor 

In this episode, Elsevier’s Holly J. Falk-Krzesinski, PhD, and Lesley Thompson, PhD, talk all things research strategy. During a wide-ranging discussion, they look at what’s changing for universities and the myriad factors driving those changes, including: 
Shifts in funding The growth of open science An increased focus on societal impact, including the UN SDGs The rise of international collaboration (and associated tensions around intellectual property) “A growing number of universities at all levels in the US are instituting research development units to help bring life to their research strategies and complement the work that the researchers and faculty members are doing….And the value add to the institution isn't just the immediate research dollars or support for the involved investigators, but it is really capacity building for the institution, and those capacity building opportunities then drive some of the changes to the institution's research strategy.”
- Dr. Holly J. Falk-Krzesinski, PhD 

See full show notes

We delved into the archives for this compilation episode. With society facing challenges on an unprecedented scale, debates are rife around the question, “How should universities and their researchers prioritize research outcomes with societal impact.”
In our two Bye Bye Blue Sky episodes and our interview on Societal Impact, SDG Research & Universities, societal impact was a popular topic of discussion.
This episode draws together the insights of those three guest experts. You’ll hear from:
Professor Lee Cronin, Regius Chair of Chemistry at the University of Glasgow in the UK, heads up the Cronin Group, whose research interests include finding alien lifeDr. Andrew Hamilton, President of New York University in the US, whose research focuses on improving the treatment of conditions like cancerAnd Professor Aluísio Segurado, who successfully juggles his twin roles as Professor of Infectious Diseases and Head of Research at Brazil’s University of São Paulo.

In this episode, Carlos Henrique de Brito Cruz, Elsevier’s Senior Vice President of Research Networks, talks collaborations.  
As a former researcher, university leader, funder, and now an enabler of collaborations, Carlos has a unique perspective on these partnerships. During the course of this interview, he discusses the range of partnership models available and reflects on some of their pros and cons
The important role of the “triple helix” structure Why international collaboration is on the rise How data can help universities and industry identify partners and track the impact The dangers of misusing data Why long-term thinking is crucial when it comes to collaborations  

Collaboration between industry and academia – it’s a topic that divides many scientists. For every researcher eager to embark on a new partnership with a corporate, there’s another hesitant to commit. But with public funding tight, and the issues that face society growing in complexity and urgency, the importance of these collaborations is increasing.
This episode features GlaxoSmithKline’s Director of Academic Liaison, Malcolm Skingle, who has more than 20 years’ experience working on these collaborations. With the help of old friend and Elsevier Vice President of Academic Relations, Lesley Thompson, he explores:
The benefits these partnerships bring – to both industry and universities/researchers.Some of the “myths” surrounding collaborations, from industry being anti-open science to suppressing researcher publications.The key questions universities should ask before signing on the dotted line.Featured in this episode (Link to full show notes here)

Professor Malcolm Skingle
Director of Academic Liaison at GlaxoSmithKline and guest speaker
Malcolm has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for over 40 years and gained a wide breadth of experience in the management of research activities. He coordinates Academic Liaison at GSK, managing staff in the US and UK. He sits on many external bodies, including the REF2021 Main Panel A and the BBSRC Council, and chairs several groups. Malcolm was awarded a CBE in 2009 in recognition of his contribution to the pharmaceutical industry. He has also been awarded an Honorary Professorship from the University of Birmingham and an honorary DSc from the University of Hertfordshire. Malcolm was elected a Fellow of the Faculty of Medicine at Imperial College London in 2011 and an honorary fellow of the British Pharmacological Society in 2020

Lesley Thompson, PhD
Vice President Academic Relations at Elsevier and guest host

Lesley joined Elsevier in 2016 as Director Academic & Government Strategic Alliance in the UK. Previously, she worked for 26 years at the Engineering and Physical Sciences Research Council (EPSRC), the largest of the UK’s seven research councils. At Elsevier, Lesley plays a leading role in advancing Elsevier’s initiatives to help universities, funding bodies and governments achieve their strategic objectives. She is a member of the Royal Society Diversity group, and, in January 2016, was awarded an MBE for services to research. Lesley has a PhD in Biology from the University of Essex and is married with children.

Giacomo Mancini, PhD
Business Development Manager at Elsevier and lead host of the Research 2030 podcast
Giacomo is a Business Development Manager at Elsevier and lead host of Elsevier’s Research 2030 podcast series. He received his PhD in Developmental and Evolutionary Biology from New York University and has a vast amount of research experience, having held positions as a Scientist and Research Associate at Johnson & Johnson and Mount Sinai Innovative Partners. While he’s passionate about analytics and bibliometrics, you may also find him reading the sports section of fivethirtyeight.com or tracking MLB player statistics on baseballreference.com. Go Mets!